Breaking News, Financial News

Financial Report: Catalent Pharma Solutions

Catalent Pharma Solutions

4Q Revenues: $451.3 million (+5%)

4Q Loss: $168.7 million (earnings were $27.6 million 4Q2006)

FY Revenues: $1.7 billion (+6%)

FY Loss: $127.3 million (earnings were $51 million FY2006)

Comments: FY and 4Q revenue growth was primarily driven by the Packaging Services segment, particularly within Europe, as well as from continued strong demand for Zydis products within the Oral Technologies segment. Packaging Services revenue was $138 million in the quarter, up 11% and for the year was $552 million, up 14%. In April 2007, an affiliate of The Blackstone Group acquired the company from Cardinal Health for approximately $3.3 billion.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters